Published in Blood Weekly, September 9th, 2004
The advisory committee's 15-1 vote supporting licensure was made July 24, 2004, after Roche Molecular Systems (RMS) presented results from their clinical study at a meeting of the BPAC. The test is the first nucleic acid test designed for screening whole blood for HBV to be accepted for review by the FDA.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.